What “99% Peptide Purity” Does—and Does Not—Prove
Why one impressive percentage cannot answer identity, quantity, provenance, or every contamination question.
This article explains analytical evidence and reporting. It does not provide medical advice, product-use instructions, treatment recommendations, or conclusions about individual safety.
01
First ask: 99% of what?
A reported percentage has meaning only inside a defined analytical procedure. The report should state the method, detector, sample preparation, integration approach, calculation basis, and which observed components were included or excluded.
For chromatographic purity, a result may represent the target peak's share of integrated detector response under the stated conditions. It should not be silently rewritten as 99% of the vial's total mass or as proof that every unobserved component is absent.
02
Purity and identity answer different questions
A chromatogram can show separation and relative detector response, while identity-supporting measurements address whether the target peak is consistent with the claimed molecule. A clean dominant peak without suitable identity evidence can still leave the central question unresolved.
For a peptide record, readers should look for an explicit sequence or chemical identifier, expected molecular mass, the observed identity-supporting result, and an explanation of the acceptance rule. Naming HPLC or mass spectrometry without showing interpretable results is not equivalent to presenting the evidence.
03
A percentage does not establish vial quantity
Relative purity and total amount are separate measurements. A report can show a high relative purity result without establishing that an individual vial contains its labeled mass. Quantity claims require an appropriate quantitative method, calibration, units, and a sample connected to the represented lot.
Likewise, a purity result should not be expanded into conclusions about sterility, endotoxin, residual solvents, counterions, water content, or other specified attributes unless those questions were separately tested and reported.
04
Read the chromatogram beyond the headline
Inspect whether the report provides retention time, run time, axes, peak table, integration boundaries, method conditions, and a legible chromatogram tied to the same sample identifier. Cropped images and percentages without context are harder to evaluate.
Also ask whether the method is selective for expected impurities and whether closely eluting components could be hidden inside the reported peak. Method suitability matters more than the prestige of an isolated number.
Supported by [1]
05
The defensible way to state the result
Prefer bounded wording: the tested sample produced a stated result under a named method on a stated date. Keep the result attached to that sample, lot, laboratory, and method.
Do not turn 99% into a universal quality badge, a product-safety conclusion, or evidence of a biological outcome. It is one analytical result whose value depends on identity evidence, method fitness, traceability, and transparent reporting.
SOURCES
References
- Eurachem — Fitness for Purpose of Analytical MethodsEurachem
- FDA FVM Program — Guidelines for Validation of Chemical MethodsU.S. Food and Drug Administration
- NIST Technical Note 1297 — uncertainty of measurementNational Institute of Standards and Technology
References are classified as official standards-body, government, or metrology guidance. Inclusion does not imply endorsement of GG Labs Research or Golden Goose Labs.